Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Enliven Therapeutics (ELVN) Blogger Opinions & Sentiment

Blogger Sentiment

Bullish: 87.50%
Sector Average
Bullish
ELVN Blogger sentiment is based on 8 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
  • 62%Investing
  • 25%GuruFocus
  • 13%SeekingAlpha

Top Blogger Bearish Predictions

  • Enliven Therapeutics: Continuing The Pop Off; What Could Go Wrong?
    4 months agoSeekingAlpha

Top Blogger Bullish Predictions

  • Barclays Initiates Coverage on Enliven Therapeutics (ELVN) with Buy, Highlighting 31% Upside
    3 months agoGuruFocus
  • William Blair initiates Enliven Therapeutics stock with outperform rating
    3 months agoInvesting

Financial Blogger Predictions​​

Blogger Performance
Rating
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow
12 days ago
14 days ago
last month
3 months ago
3 months ago
Guggenheim
Investing.com
3 months ago
Bullish
Guggenheim lowers Enliven Therapeutics stock price target to $78
Galzus Research
Seeking Alpha
4 months ago
Bearish
Enliven Therapeutics: Continuing The Pop Off; What Could Go Wrong?
Renato Neves
Seeking Alpha
7 months ago
Bullish
Ero Copper: A Copper Growth Story Trading at a Discount

FAQ

What do Seeking Alpha bloggers think of ELVN?
Seeking Alpha’s Galzus Research has a Bearish Sentiment.
What do Motley Fool contributors think of ELVN?
Currently there's no blogger sentiment for ELVN.
What Is ELVN’s Blogger Sentiment?
ELVN’s Blogger Sentiment is Bullish.
What was the most recent blogger prediction for ELVN?
The most recent blogger prediction for ELVN was made by NASDAQ:ELVN, who was Bullish on the stock.
How can I follow the stock ratings of top Top Financial Bloggers?
Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.